CLLS
Cellectis

2,608
Mkt Cap
$223.13M
Volume
73,482.00
52W High
$5.48
52W Low
$1.10
PE Ratio
-6.37
CLLS Fundamentals
Price
$3.63
Prev Close
$3.58
Open
$3.63
50D MA
$3.31
Beta
1.18
Avg. Volume
127,737.90
EPS (Annual)
-$0.4052
P/B
3.75
Rev/Employee
$186,629.20
Loading...
Loading...
Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquartered in Paris, France.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
222

Frequently Asked Questions

What is Market Cap of Cellectis - ADR?
What is the 52-week high for Cellectis - ADR?
What is the 52-week low for Cellectis - ADR?
What is Cellectis - ADR stock price today?
What was Cellectis - ADR stock price yesterday?
What is the PE ratio of Cellectis - ADR?
What is the Price-to-Book ratio of Cellectis - ADR?
What is the 50-day moving average of Cellectis - ADR?
How many employess does Cellectis - ADR has?

Latest CLLS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.